Aseana Properties : Quarterly Investor Update

Quarterly Investor Update

Released : 29/03/2019 07:00

RNS Number : 3240U

Aseana Properties Limited

29 March 2019

29 March 2019

Aseana Properties Limited

("Aseana")

Quarterly Investor Update

Aseana Properties Limited (LSE: ASPL), a property developer in Malaysia and Vietnam, listed on the Main Market of the London Stock Exchange, has issued its Quarterly Investor Update for the three month period to 31 December 2018, a copy of which can be obtained from Aseana's website at: http://www.aseanaproperties.com/quarterly.htm

Highlights:

∙Sales of The RuMa Residences have reached approx. 68% to date, based on sale and purchase agreements signed. The RuMa Hotel which began operations on 30 November 2018 has recorded an average occupancy of 22% based on available inventory.

∙The Harbour Mall Sandakan ("HMS") is approx. 78% leased to date.

∙Four Points by Sheraton Sandakan Hotel ("FPSS") recorded an average occupancy rate of approx. 39% for the year up to 31 December 2018 and 35% for the current year to date.

For further information:
Aseana Properties Limited	Tel: [phone]
Chan Chee Kian	Email:
	[e-mail]
N+1 Singer	Tel: [phone]
James Maxwell / James Moat (Corporate Finance)
Sam Greatrex (Sales)
Tavistock	Tel: [phone]
Jeremy Carey / James Verstringhe	Email:
Notes to Editors:	[e-mail]

London‐listed Aseana Properties Limited (LSE: ASPL) is a property developer investing in Malaysia and Vietnam.

Ireka Development Management Sdn Bhd ("IDM") is the exclusive Development Manager for Aseana. It is a wholly‐owned subsidiary of Ireka Corporation Berhad, a company listed on the Bursa Malaysia since 1993, which has over 52 years' experience in construction and property development. IDM is responsible for the day‐to‐day management of Aseana's property portfolio and the divestment of existing properties.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] visit www.rns.com.

END

MSCUWVKRKVAOURR